Home
Blue Owl Capital Holdings reported a 5.92% stake in Aktis Oncology AKTS · 3,161,348 sh · passive holder
Trade details
- Type
- 5% stake report
- Report
- 13G passive
- Stake
- 5.92%
- Last report
- First report
- Shares held
- 3,161,348 sh
- Class
- Common Stock, par value $0.0001 per share
- Stock
- Aktis Oncology AKTS
- Event date
- 26/03/31
- Filed
- 26/05/14
First 5%+ report · 5.92% stake
Aktis Oncology trades, last 26 weeks
What else happened in Aktis Oncology around then
Filed or reported within 30 days of the trade day · 03/01~04/30Blue Owl Capital Holdings's other 5% stake reports
- Blue Owl Capital Holdings
5% stakeContext Therapeutics
5% stakeContext Therapeutics
CNTX
3.19% stake
2,934,015 sh
3.19% stake
Filed 08/12
- Blue Owl Capital Holdings
5% stakeContext Therapeutics
5% stakeContext Therapeutics
CNTX
5.54% stake
5,089,015 sh
5.54% stake
Filed 05/14
- Blue Owl Capital Holdings
5% stakeImageneBio
5% stakeImageneBio
IMA
8.51% stake
959,337 sh
8.51% stake
Filed 05/14
- Blue Owl Capital Holdings
5% stakeFinance of America Companies
5% stakeFinance of America Companies
FOA
9.49% stake
827,409 sh
9.49% stake
Filed 02/12
- Blue Owl Capital Holdings
5% stakeFS Credit Opportunities
5% stakeFS Credit Opportunities
FSCO
0% stake
0 sh
0% stake
Filed 02/12
